Cancer cachexia is a debilitating condition characterized by weight loss and muscle wasting in patients with advanced cancer. This condition intertwines physical and mental health, as feelings of hopelessness and apathy often exacerbate the physical deterioration. Recent studies highlight the neuroimmune connection that fuels this relationship, suggesting that targeting inflammatory factors, such as with IL-6 blockers, can ameliorate the psychological aspects without impacting the tumors themselves. Thus, personalized therapies that simultaneously address both the mind and body are emerging as crucial for better managing cancer cachexia and improving patients' quality of life.
Cachexia is characterized by severe weight loss and muscle wasting.
Neuroimmune circuit links body inflammation to brain apathy and cachexia.
IL-6 blockers can reverse apathy without affecting tumors.
Personalized therapies target both mind and body symptoms of cancer cachexia.
Collection
[
|
...
]